Skip to main content
OpenTrials

Clinical trial condition

C3 Glomerulopathy

Explore clinical trials studying C3 Glomerulopathy. Study availability and eligibility vary by location and protocol.

16 public trials 5 recruiting studies

C3 Glomerulopathy trial results

Conditions
C3 Glomerulopathy, Idiopathic Immune Complex-Mediated Glomerulonephritis
Locations
  • Omeros Investigational Site Kaunas, Lithuania
  • Omeros Investigational Site Vilnius, Lithuania
  • Omeros Investigational Site Auckland, New Zealand
  • Omeros Investigational Site Lodz, Poland
Conditions
Autoimmune Diseases, C3 Glomerulopathy, Female Urogenital Diseases, +11 more
Locations
  • Peking University First Hospital Beijing, China
  • Peking University People's Hospital Beijing, China
  • The Third Xiangya Hospital of Central South University Changsha, China
  • Sichuan Provincial People's Hospital Chengdu, China
Conditions
Autoimmune Diseases, C3 Glomerulopathy, Female Urogenital Diseases, +10 more
Locations
  • Research Site 1 Camperdown, New South Wales, Australia
  • Research Site 3 Concord, New South Wales, Australia
  • Research Site 2 Clayton, Victoria, Australia
  • Research Site 2 Tbilisi, Georgia
View all 16 locations
Conditions
C3 Glomerulonephritis, C3 Glomerulopathy, C3G, +19 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Keck School of Medicine, University of Southern California Los Angeles, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 25 locations